WNT signaling in glioblastoma and therapeutic opportunities.
about
Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR GammaA Systemic Analysis of Transcriptomic and Epigenomic Data To Reveal Regulation Patterns for Complex DiseaseResveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling PathwayDifferentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates.Overexpression of FZD7 promotes glioma cell proliferation by upregulating TAZ.Modeling Intercellular Communication as a Survival Strategy of Cancer Cells: An In Silico Approach on a Flexible Bioinformatics Framework.Isolation, identification, and characterization of cancer stem cells: A review.Wnt/beta-catenin pathway: modulating anticancer immune response.Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells.Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line.Integrating the glioblastoma microenvironment into engineered experimental models.Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiologyTargeting WNT Signaling for Multifaceted Glioblastoma Therapy.Towards Clinically More Relevant Dissection of Patient Heterogeneity via Survival based Bayesian Clustering.Culture on 3D Chitosan-Hyaluronic Acid Scaffolds Enhances Stem Cell Marker Expression and Drug Resistance in Human Glioblastoma Cancer Stem Cells.3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy.MicroRNA-target cross-talks: Key players in glioblastoma multiforme.Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.Developmentally regulated signaling pathways in glioma invasion.How to analyse the spatiotemporal tumour samples needed to investigate cancer evolution: A case study using paired primary and recurrent glioblastoma.The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor.Comparison of EMT mediated tyrosine kinase inhibitor resistance in NSCLC.The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter.Glioblastoma: new therapeutic strategies to address cellular and genomic complexity.Wnt signaling in cervical cancer?Propofol inhibits Wnt signaling and exerts anticancer activity in glioma cells.Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide.Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).R-spodin2 enhances canonical Wnt signaling to maintain the stemness of glioblastoma cells
P2860
Q33748280-A95628DC-01CA-44A7-930E-B277672C9198Q33877366-03BBC809-1098-43E8-99F1-C11DBCAB4C93Q36247757-A6615228-6730-46E5-A9C2-2FD7AAF45EEBQ36370196-CA891360-8D71-478D-AA0A-0BC84292101DQ37699166-5F0652C4-0028-4224-9FC9-D2892495A1F2Q38892442-961395A0-C4FF-4506-8AFC-AF385C014EE6Q39055537-28743B44-4B24-4668-BBD8-AAC5906F7D21Q39286193-1C67B5B5-8FC4-4193-A94E-980809D06CC7Q39404706-2971E0FB-B9F1-48C7-B2A1-1E3D66FC0C40Q40064435-AA55BD97-F791-4067-8EF3-E4425E91A0FFQ41609024-812B2DF6-940C-4DB4-A2E8-93D023FAD15FQ41809872-DC10B4DF-83ED-408B-AC89-5645357A34ADQ42284739-DBF5A8AE-3176-4B28-B773-D14C34BCEE33Q42683185-FB9B75D2-0207-4737-AF99-678EF991E1F3Q42696739-1ACE7100-0DDD-4B25-923D-3FB5D913E745Q45893116-6E658AAC-6491-444A-BE2E-01CBA76C7C04Q46025187-551122CB-9611-400C-B2A6-DA2FBEE5BBA8Q46190130-25952BEE-567A-472B-AC94-80CC901FFCD2Q47294523-49308E9F-28A0-4D8C-B839-133B83C88BF0Q48148598-D11F5137-B2E5-4B10-A6B7-A6F55A55D1BBQ48197743-3A455A8C-9724-42EB-A67B-C0D3BBEDA9FFQ49804881-44A40C26-4241-43F1-BE23-CA2E3505DC62Q50033862-8F43B1B0-D573-4EB8-AB15-946CED3BA676Q52324277-0DE0E560-6D7A-4F7A-8F35-C5BA13E19838Q52366335-5EA903A3-B3BB-41C5-84C0-33B7B4338034Q55017017-AA165757-F393-47D9-9519-41ED506E1689Q55279534-ED0264F0-F52A-4CC7-A821-592089BF84A9Q55327757-80317B23-E1CC-4DC7-8BDE-73BA6AE689FAQ55509415-96BD2E90-C298-47B7-A037-CA40C9C317FBQ58572053-B59167F8-D6BD-4328-8C0D-BDC98CD9817E
P2860
WNT signaling in glioblastoma and therapeutic opportunities.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
WNT signaling in glioblastoma and therapeutic opportunities.
@en
type
label
WNT signaling in glioblastoma and therapeutic opportunities.
@en
prefLabel
WNT signaling in glioblastoma and therapeutic opportunities.
@en
P2093
P2860
P1476
WNT signaling in glioblastoma and therapeutic opportunities.
@en
P2093
Do-Hyun Nam
Jeongwu Lee
Jin-Ku Lee
Sun Hee Ahn
P2860
P2888
P304
P356
10.1038/LABINVEST.2015.140
P577
2015-12-07T00:00:00Z
P5875
P6179
1025673114